v3.26.1
Note 10 - Segment Information (Tables)
3 Months Ended
Mar. 31, 2026
Notes Tables  
Segment Reporting [Table Text Block]
   

Three months ended March 31,

 
    2026    

2025

 

Revenue

  $     $ (27 )

Employee expense (not including stock-based compensation)

    1,635       1,338  

Development and clinical trial expense

    919       458  

Other general and administrative expense(a)

    1,076       927  

Other segment income, net(b)

    (1,074 )     (30 )

Discontinued operations

          (73 )

Segment and condensed consolidated net loss

  $ (2,556 )   $ (2,593 )